Testing a new drug NTB003 in healthy volunteers
This early-phase trial tests the safety of a new drug called NTB003 in healthy people. It looks at how the drug moves through the body and affects it, which is a first step toward possibly treating certain conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 25 and 45 years old.
- Your body mass index (BMI) is between 19 and 26, and you weigh at least 50 kg (men) or 45 kg (women).
- You are generally healthy, with no major illnesses like heart, lung, or mental health conditions.
- You agree to use reliable birth control during the study and, if female, have a negative pregnancy test.
- You have not taken any medications, including over-the-counter drugs or supplements, in the last 2 weeks.
- You do not smoke more than 5 cigarettes a day and can avoid tobacco during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine called MT-201 to see if it is safe and how the body handles it. It is for healthy volunteers aged 19 to 55 who are willing to follow study rules.
This trial tests different doses of a new study drug in healthy people to see how safe it is and how the body handles it. Participation involves taking the drug and having regular check-ups.
This study tests a new medicine called NNC0705-0002 in healthy volunteers to see if it is safe and how the body handles it. It helps find the right dose for future studies.
This is a first-in-human study to test an investigational drug called PSTB100 in healthy adults. The purpose is to see how the body handles the drug and to check for any side effects. Participation may help with future treatment development.
This study tests a new investigational drug called TBN in healthy volunteers to see if it is safe and how the body processes it. It's an early phase trial, so it's not about treating a disease but about understanding the drug's effects.
This study tests a new medication (NTB003) for people with thyroid eye disease (TED), a condition that can cause bulging eyes, double vision, and discomfort. It aims to see if the treatment is safe and helps reduce symptoms.
Hear when a new TED trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.